Asian Paints Subsidiaries Approve Amalgamation Scheme with Board Resolution
Asian Paints' subsidiary companies have approved an amalgamation scheme where Nova Surface-Care Centre will merge with Harind Chemicals and Pharmaceuticals. The board approval was granted on March 24, 2026, with the transaction designed to streamline operations and reduce administrative costs while having no material financial impact on the parent company.

*this image is generated using AI for illustrative purposes only.
Asian Paints ' subsidiaries Harind Chemicals and Pharmaceuticals Private Limited and Nova Surface-Care Centre Private Limited have received board approval for their amalgamation scheme on March 24, 2026. The boards of both subsidiary companies approved the Scheme of Amalgamation with Nova as the Transferor Company and Harind as the Transferee Company, subject to regulatory approvals.
Board Approval and Regulatory Framework
The amalgamation was formally approved at the respective board meetings held on March 24, 2026. Asian Paints has informed stock exchanges BSE and NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company emphasized that this scheme will not have any material impact on its financials.
| Parameter: | Details |
|---|---|
| Approval Date: | March 24, 2026 |
| Transferor Company: | Nova Surface-Care Centre Private Limited |
| Transferee Company: | Harind Chemicals and Pharmaceuticals Private Limited |
| Regulatory Status: | Subject to Regulatory Approvals |
| Financial Impact: | No Material Effect Expected |
Company Structure and Financial Details
Nova Surface-Care Centre is a wholly-owned subsidiary of Harind Chemicals, while Asian Paints holds a 51% stake in Harind. Nova was incorporated on September 7, 2011, and Harind on June 6, 1995. The financial performance as of March 31, 2025, shows significant size differences between the entities.
| Company: | Net Worth (₹ crores) | Turnover (₹ crores) |
|---|---|---|
| Nova Surface-Care Centre: | 0.49 | 0.08 |
| Harind Chemicals: | 18.81 | 37.87 |
Business Operations and Strategic Rationale
Nova operates in testing services for paints and related chemicals, while Harind manufactures and deals in chemical products related to paints. The amalgamation rationale centers on operational efficiency, as Nova's laboratory capacity is exclusively used by Harind with minimal third-party commercial engagements.
The company stated that operating Nova as a separate entity is no longer strategically necessary. The amalgamation will streamline operations, reduce regulatory compliance multiplicity, generate administrative cost economies, and facilitate consolidated management.
Transaction Structure
The amalgamation involves no cash consideration as Harind holds Nova's entire share capital through itself and nominees. Upon scheme effectiveness, all Nova equity shares will be cancelled and extinguished. The transaction qualifies as a related party transaction conducted at arm's length in ordinary business course, with requisite Audit Committee approvals obtained.
Source: Company/INE021A01026/6892fa43-e94c-4cd6-b1af-4a0d8d15d8c0.pdf
Historical Stock Returns for Asian Paints
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.77% | -2.42% | -8.65% | -8.18% | -5.29% | -8.11% |
Will Asian Paints pursue similar consolidation strategies across its other subsidiary portfolio to achieve operational efficiencies?
How might the streamlined operations impact Asian Paints' competitive positioning in the chemical testing and manufacturing segment?
What timeline is expected for obtaining the necessary regulatory approvals for this amalgamation scheme?


































